Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial
- 31 March 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 31 (3) , 487-493
- https://doi.org/10.1016/s0735-1097(97)00553-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of Saruplase and Alteplase in Acute Myocardial InfarctionThe American Journal of Cardiology, 1997
- Decline in the rate of hospital mortality from acute myocardial infarction: Impact of changing management strategiesAmerican Heart Journal, 1996
- Acute myocardial infarction: pre-hospital and in-hospital management: The Task Force on the Management of Acute Myocardial Infarction of the European Society of CardiologyEuropean Heart Journal, 1996
- Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study)Journal of the American College of Cardiology, 1995
- Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalenceThe Lancet, 1995
- Link Between the Angiographic Substudy and Mortality Outcomes in a Large Randomized Trial of Myocardial ReperfusionCirculation, 1995
- Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.Circulation, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992